Skip to search formSkip to main contentSkip to account menu

LMP2A-Specific Cytotoxic T-Lymphocytes

Known as: LMP2A-CTL, EBV-Specific Cytotoxic T-Lymphocytes, LMP2A CTL 
A preparation of cytotoxic T-lymphocytes (CTL), specifically reactive to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP2A), with potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
CD8+ effectors are critical components of type 1 responses against viral infections as well as for antiviral vaccines. IL-4 plays… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT We have optimized the induction of antiviral cytotoxic T lymphocytes (CTL) in rhesus macaques by a lipopeptide vaccine… 
Highly Cited
1998
Highly Cited
1998
ABSTRACT CD8+ cytotoxic T lymphocytes (CTL) play a key role in the control of many virus infections, and the need for vaccines to… 
Highly Cited
1998
Highly Cited
1998
Melan‐A/MART‐1 is a melanoma differentiation antigen that is recognized by a high proportion of cytolytic T lymphocyte (CTL… 
Highly Cited
1996
Highly Cited
1996
To determine whether HLA-A21 restricted melanoma Ags exist that are not expressed on normal melanocytes, a panel of 478 T cell… 
Highly Cited
1993
Highly Cited
1993
Transplantation with bone marrow from other than genotypically HLA-identical donors is associated with an increased incidence and… 
Highly Cited
1992
Highly Cited
1992
The oxidative metabolism of L-arginine to its bioactive product, nitric oxide (.N = O) has been shown to inhibit rat splenocyte… 
Highly Cited
1991
Highly Cited
1991
The objective of this study was to elucidate the interaction of naturally occurring soluble MHC class I molecules with… 
Highly Cited
1986
Highly Cited
1986
Spleen cells from DBA/2 mice, after immunization with syngeneic P815 mastocytoma cells and Corynebacterium parvum, respond to… 
Highly Cited
1984
Highly Cited
1984
The specificity of the T-accessory cell interactions that initiate primary allospecific cytotoxic T lymphocyte (CTL) responses…